Cytochrome P-450-dependent 6/J-hydroxylation of bile acids in rat liver contributes to the synthesis of the quantitatively important pool of 6-hydroxylated bile acids, as well as to the detoxification of hydrophobic bile acids. The lithocholic acid 6,f-hydroxylation reaction was investigated and compared with androstenedione 6,8-hydroxylation. Differential responses of these two activities to inducers and inhibitors of microsomal P-450 enzymes, lack of mutual inhibition by the two substrates and differential inhibition by antibodies raised against several purified hepatic cytochromes P-450 were observed. From these results it was concluded that 6/3-hydroxylation of lithocholic acid is catalysed by P-450 form(s) different from the subfamily IIIA cytochromes P-450 which are responsible for the bulk of microsomal androstenedione 6,l-hydroxylation. Similar, but more tentative, results revealed that the 7a-hydroxylation of lithocholic acid and of androstenedione may be also catalysed by distinct P-450 enzymes. The results indicate that cytochromes P-450 hydroxylating bile acids are distinct from analogous enzymes that carry out reactions of the same regio-and stereospecificity on neutral steroids (steroid hormones). A comparison of pairs of cytochromes P-450 that catalyse the same reaction on closely related steroid molecules will help to define those structural elements in the proteins that determine the recognition of their respective substrates.
INTRODUCTION
The conversion of cholesterol into bile acids involves several key cytochrome P-450-dependent hydroxylation reactions, including the rate-limiting step of the process, namely cholesterol 7a-hydroxylation. These reactions play an important role in both cholesterol homoeostasis and bile acid biosynthesis, and have been studied in some detail [1] . The bile acids formed in this manner are not metabolically inert terminal cholesterol catabolites, but are subject to numerous interconversions, some of which again involve hydroxylation reactions [2] . These hydroxylations can be distinguished from those required for bile acid biosynthesis in so far as the latter reactions do not proceed with fully formed bile acid molecules as substrates [1] .
Hydroxylation of a bile acid molecule decreases its hydrophobicity. Since bile acids are, in the course of the enterohepatic circulation, constantly exposed to the action of intestinal microflora which can cause the loss of hydroxyl groups [3] , rehydroxylation is essential in restoring the hydrophilichydrophobic balance required for the physiological functions of bile acids. Rehydroxylation also prevents the toxicity that is characteristic of very hydrophobic bile acids, such as the monohydroxylated lithocholic acid (3az-OH). More generally, hydroxylation of bile acids becomes important in any situation, physiological or pathological, in which the hydrophilic-hydrophobic balance of bile acids as a group (loosely translatable into the ratio of trihydroxylated to dihydroxylated bile acids) is disturbed.
In the rat, considerable amounts of 6fl-hydroxylated bile acids (approx. 200% of the total bile acid pool [4] ) are found. The predominant of these compounds, ,J-muricholic acid (3a, 6, 8, , is thought to be formed by 6/)-hydroxylation of chenodeoxycholic acid (3a,7a-diOH) to a-muricholic acid (3af,6/,7a-triOH), followed by epimerization of the 7a-hydroxy group [5] [6] [7] [8] [9] [10] [11] [12] (Fig. 1 ). This biosynthetic reaction, which takes place under normal physiological conditions, probably evolved as a means of maintaining a ratio of tri-to di-hydroxylated bile acids that is compatible with the functions of the bile acid pool. The 6/3-hydroxylation of bile acids has, however, an additional role. Certain monohydroxylated bile acids are too hydrophobic to contribute to the physiological functions of bile acids; on the other hand, these compounds are hepatotoxic through an only partially understood mechanism. Lithocholic acid (3a-OH), formed mainly by bacterial 7a-dehydroxylation of chenodeoxycholic acid (3a,7a-diOH), and 3,8-hydroxychol-5-enoic acid, probably a product of a minor pathway of direct bile acid biosynthesis from cholesterol [13] , are the two major examples of such compounds. It is fairly well established, at least for lithocholic acid, that one of the main detoxification reactions is 6-hydroxylation (see Discussion in [14, 15] ). In the rat, 6,J-hydroxylAbbreviations used: lithocholic acid, 3a-hydroxy-5/J-cholanoic acid; chenodeoxycholic acid, 3a.,7cc-dihydroxy-5,-cholanoic acid; cholic acid, 3a,7cx,12a-trihydroxy-5/J-cholanoic acid; murideoxycholic acid, 3a,6fl-dihydroxy-5fl-cholanoic acid; a-muricholic acid, 3a,6,8,7a-trihydroxy-5fl-cholanoic acid; /8-muricholic acid, 3a,6,8,7,8-trihydroxy-5,8-cholanoic acid; for clarity, the positions of the hydroxyl groups are occasionally given in the text after the trivial name as derivatives of 5fl-cholanoic acid, e.g. murideoxycholic acid (3a,6fi-diOH); androstenedione, androst-4-ene-3,17-dione; 4-MA, 17,8-(N,N-diethylcarbamoyl)-4-aza-4-methyl-5Sa-androstan-3-one; metyrapone, 2-methyl-1,2-bis(3-pyridyl)-l-propanone; trans-tamoxifen, [5] [6] [7] [8] [9] [10] [11] [12] . Bacterial 7a-dehydroxylation of chenodeoxycholic acid leads to the formation of lithocholic acid. The latter is efficiently 6,8-hydroxylated [18] , and the intermediate murideoxycholic acid can be further transformed into f,-muricholic acid, either through 7a-hydroxylation followed by epimerization, or through a hypothetical 7fl-hydroxylation [6] . ation predominates [7, [16] [17] [18] (Fig. 1) . The murideoxycholic acid (3af,6/-diOH) formed from lithocholic acid by 6,/-hydroxylation can re-enter the main bile acid pool through subsequent further hydroxylation to the muricholic acids [18] . This series of reactions has therefore both a detoxification and a salvage function.
In spite of the physiological importance of bile acid 6fl-hydroxylation in the rat, the enzymology of the process has not been studied in detail. Early work demonstrated that the reaction is catalysed by cytochrome P-450 [7, 19, 20] . Since the multiplicity of cytochromes P-450 was not fully appreciated at that time, the specific P-450 enzyme(s) involved were not identified. The formally analogous 6fl-hydroxylation reaction of a different steroidal substrate, androstenedione, known to be catalysed in rat liver microsomes primarily by the constitutive cytochrome P-4501IIA2 and the inducible cytochrome P-450IIIA1 [21] , initially suggested that lithocholic acid may be 6,J-hydroxylated by the same enzyme(s). The present work proves that this is not the case; distinct forms of P-450 are involved in the hydroxylation of each substrate.
MATERIALS AND METHODS

Animals
Male [24] . Labelled products were detected by autoradiography (48-96 h exposure on Kodak X-OMAT AR film at -80 'C) and quantified by scraping of zones containing the compounds of interest followed by scintillation counting. Products were identified by comparison with authentic standards.
Antibody and inhibition studies
Inhibition of microsomal androstenedione, testosterone and lithocholic acid 6,f-hydroxylation by anti-P-450 antibodies was measured essentially as described above, with the following modifications. bath, and the assays were started by the addition of NADPH. In the inhibition studies, metyrapone, trans-tamoxifen, ketoconazole and clotrimazole, dissolved in ethanol, were added directly to standard assays carried out as described in the previous section. The final concentration of ethanol in the assay was kept below 0.5 %, a concentration which had no effect on the activities measured.
Materials
Polyclonal anti-P-450 antibody IgG fractions were prepared from rabbits immunized with purified rat liver P-450 forms designated p (P-450IIIA1) [25] , PCNb (P-450IIIA2) [26, 27] , PB1 (P-4501IC6) [28] , and RLM2 (P-450IIA2) [29] using standard methods. Antibodies to P-450p and P-45OPCNb used in this study were kindly provided by Dr [21] and lithocholic acid [18] are both hydroxylated at multiple sites by isolated rat liver microsomes, with the 6/3-hydroxy derivatives formed as major metabolites with each compound. The influence of several mono-oxygenaseinducing agents, administered to adult male and female rats, on the rates of hydroxylation of these compounds at the 6/1 and 7a positions is shown in Table 1 . Androstenedione 6/3-hydroxylation was induced in male rats by phenobarbital, dexamethasone and clofibrate, whereas only the first two compounds induced this activity in female rats. In contrast, lithocholic acid 6,-hydroxylation was enhanced in male rats by phenobarbital and clofibrate, while in females all three inducers used were effective. When both androstenedione and lithocholic acid 6/1-hydroxylation was increased by an inducer, the degree of induction was in most cases significantly different for the two substrates ( Table  1) . Examination of the microsomal 7a-hydroxylation rates for both substrates also revealed differences in their response to mono-oxygenase inducers, in particular in the case of dexamethasone, which stimulated lithocholic acid 7a-hydroxylase but not androstenedione 7az-hydroxylase in both male and female rats. Since the 6,/-hydroxylation of lithocholic acid is the quantitatively predominant [18] and physiologically most interesting hydroxylation reaction involving this substrate, further work focused on this process.
The inducibility patterns presented in Table 1 suggested that hydroxylations of the same regio-and stereo-specificity on androstenedione and on lithocholic acid are catalysed by distinct cytochrome P-450 forms. This prompted a more direct examination of the possible identity of the enzyme(s) involved in lithocholic acid 6/3-hydroxylation. This was accomplished using anti-P-450 antibodies that are preferentially inhibitory to select Liver microsomes from untreated male Fischer rats were assayed as described in the legend to Fig. 2 In contrast with its strong inhibitory effect on androstenedione 6f8-hydroxylation in dexamethasone-induced microsomes and its moderate inhibitory effect in uninduced microsomes, anti-P-450IIIA2 did not inhibit the 6,/-hydroxylation of lithocholic acid catalysed by either microsome preparation (Fig. 2) . Conversely, anti-P-450IIIA1, which was a comparatively weak inhibitor of androstenedione 6fl-hydroxylation, completely eliminated lithocholic acid 6,8-hydroxylation (Figs. 2a and 2b) . In contrast, a second anti-P-450IIIAl antibody used in this study was partially inhibitory toward androstenedione 6fl-hydroxylation but was ineffective against lithocholic acid 6,8-hydroxylation (results not shown).
An antibody raised against P-4501IC6, a cytochrome belonging to a different P-450 family than the two androstenedione 6/.-hydroxylases, did not significantly inhibit the latter activity in either untreated or dexamethasone-induced liver microsomes (Figs. 2e and 2J) . However, the same antibody was quite effective in inhibiting lithocholic acid 6fl-hydroxylase (Fig. 2) . Similarly (Fig. 3) , anti-P-450IIA2 inhibited lithocholic acid 6,J-hydroxylase without affecting steroid hormone 6,-hydroxylation, which in this experiment was assayed using testosterone as an alternative substrate [21] . This immunochemical cross-reactivity of the lithocholic acid 6,J-hydroxylase with members of cytochrome P-450 family II further sets it apart from the androstenedione 6,.-hydroxylase(s). No inhibition of either 6,8-hydroxylase activity was effected by antibodies reactive with the 3-methylcholanthreneinducible cytochrome P-4501A1 or the phenobarbital-inducible cytochrome P-4501IB1 (results not shown), or by non-immune rabbit IgG (Fig. 2) stenedione is a general phenomenon, rather than being restricted to a specific strain of rats.
DISCUSSION
Several independent approaches were used to demonstrate that the cytochrome(s) P-450 that catalyse microsomal lithocholic acid 6fl-hydroxylation, and perhaps 7a-hydroxylation, are disVol. 275 tinct from those that catalyse the corresponding 6,-and 7a-hydroxylations of androstenedione. This conclusion is supported by the differential response of the two activities to P-450 inducers, the lack of significant mutual inhibition of hydroxylation by the two compounds, and differential sensitivity to inhibition by compounds such as metyrapone and ketoconazole, as well as to anti-P-450 antibodies.
Induction of microsomal detoxifying enzymes, including the cytochromes P-450, by xenobiotics is common. Inducibility by a given compound is often highly characteristic for a P-450 enzyme, and can aid in its identification [37] , especially when no structural and genetic information is available. Since the expression of a number of rat hepatic cytochrome P-450s is subject to sexspecific hormonal control [21] , induction was studied in both male and female rats. The clear differences in the inducibility patterns of hepatic lithocholic acid 6,-hydroxylase and androstenedione 6,/-hydroxylase activities indicate that distinct P-450 enzymes catalyse these two microsomal reactions. A similar conclusion was reached with regard to the 7a-hydroxylation reactions ( Table 1) .
The distinctiveness of cytochromes P-450 responsible for the 6,-hydroxylations of lithocholic acid and androstenedione was confirmed by the differential responses of these activities to chemical inhibitors. While the results obtained in these experiments point to the likelihood of a multiplicity of these 6,3-hydroxylase enzymes, more specific information on their identity was provided by immunological cross-reactivity experiments (Figs. 2 and 3 ). Due to a pronounced physical similarity of microsomal cytochromes P-450 that includes sequence homology [38, 39] , the presence of highly conserved regions [40] [41] [42] and identical overall patterns of folding and membrane attachment [41, [43] [44] [45] Several purified cytochromes P-450 exhibit high androstenedione 6,8-hydroxylase activity when assayed in reconstituted systems [21, 37] . i-Iowever, in intact liver microsomes the constitutive form P-450IIIA2 and the drug-inducible form P-4501IIA1 are largely, if not solely, responsible for this reaction [21] . While some antibodies prepared against these two cytochromes also inhibited lithocholic acid 6,l-hydroxylation, there were striking differences in the behaviour of the latter activity as compared with androstenedione 6/?-hydroxylation (Fig. 2) . On one hand, this finding corroborates the conclusion that separate enzymes catalyse the two reactions. On the other hand, it suggests that the lithocholic acid 6/,-hydroxylase P-450(s) share some, but not all, epitopes with the androstenedione 6,3-hydroxylases of P-450 subfamily IIIA. This observation suggests that the lithocholic acid 6,8-hydroxylase may belong to family III. However, the partial inhibition of lithocholic acid 6/?-hydroxylation by anti-P-450IIC6 (Fig. 2) and the more complete inhibition by anti-P-4501IA2 (Fig. 3) are suggestive of some structural similarity with family II cytochromes P-450 as well. A more definitive determination of whether the lithocholic acid 6,8-hydroxylase P-450 actually belongs to P-450 family II or III requires the determination of its primary structure.
Although P-450 forms IIIA1 and IIIA2 are the major catalysts of microsomal androstenedione 6/?-hydroxylation in rat liver, several other cytochromes P-450 exhibit the same activity in purified reconstituted enzyme systems. The most prominent of these are cytochromes P-4501A1 and P-4501IC13 [21, 37] . These two enzymes can, however, be ruled out as candidates for the lithocholic acid 6,8-hydroxylase. Inhibitory antibodies against cytochrome P-450IA1 did not inhibit the latter activity, and ,?-naphthoflavone, a prototypic inducer of cytochrome P-4501A1, did not increase the level of microsomal lithocholic acid 6,l-hydroxylase activity (results not shown). The other steroid 6fl-hydroxylase, cytochrome P-4501IC13, is strain-specific and absent in Fischer rats [46] , in which the present experiments were carried out. Therefore it appears most likely that lithocholic acid 6fl-hydroxylation is catalysed by a hitherto undescribed cytochrome P-450.
The fact that the 6fl-hydroxylations of lithocholic acid and androstenedione are catalysed by distinct enzymes should be seen in a physiological as well as a mechanistic context. The functions of the two reactions are very different. Whereas the 6/?-hydroxylation of bile acids has, as indicated previously, a dual biosynthetic and detoxification/salvage role, 6,l-hydroxylation of androstenedione and other related androgens, e.g. testosterone, is likely to contribute to the inactivation and degradation of these hormones. The physiological regulatory requirements for the two reactions are obviously very different. A catabolic pathway for androgens is necessary only in the post-pubertal male. In fact, a complex hormonal regulatory system present in the rat blocks the expression of androstenedione 6/J-hydroxylase in adult females [21, 34, 47, 48] . In contrast, bile acid 6,?-hydroxylation is probably functional in both sexes throughout life [49] , and may be especially important in the perinatal period. During this period of development, the hydrophobic-hydrophilic balance of bile acids is shifted towards a relative deficiency of trihydroxylated bile acids [50] . The situation is remedied in the rat by increased 6,6-hydroxylation, as evidenced by higher levels of 6,?-hydroxylated bile acids at birth as compared with adult levels [49] . Thus, in light of the disparate physiological requirements, the separation of lithocholic acid and androstenedione 6,?-hydroxylations becomes understandable. Since our preliminary data indicate that 7a-hydroxylation of the two substrates is also catalysed by independent enzymes, it becomes likely that a group of bile acid hydroxylase P-450s exists that is distinct from the known cytochromes P-450 that hydroxylate neutral steroids, even if the positional specificity of the catalysed reactions is the same.
The discrimination between the two steroidal molecules, androstenedione and lithocholic acid, by cytochromes P-450 has interesting mechanistic implications. Despite their overall similarity, the two compounds differ in several respects (Fig. 5) . The most striking are (i) their distinctly different shapes, with androstenedione being essentially planar, while ring A of lithocholic acid is bent at an almost right angle relative to the plane of the molecule; (ii) the presence, in androstenedione but not in lithocholic acid, of a conjugated double bond system that increases the inherent chemical reactivity of position 6,/; (iii) a different substituent in position 17, i.e. an oxo group in androstenedione, and a charged and more bulky side chain in lithocholic acid. Further studies will be required to determine which of these characteristics of the two molecules are crucial for their selective recognition by the P-450 enzymes that catalyse their hydroxylation.
The two principal rat liver androstenedione 6/?-hydroxylases, cytochromes P-450IIIA1 and P-450IIIA2, have been purified [30, 34, [51] [52] [53] and reconstituted without loss of activity [34, 53, 54] , and their sequences are known [31, 55] . The identification of another cytochrome P-450, the lithocholic acid 6,8-hydroxylase, which catalyses a reaction of the same regio-and stereo-specificity on a generally similar substrate, will help to focus on the differences between the enzymes that are important for their function. In a complementary development, it has been recently determined that the human hepatic cytochrome P-450IIIA4 (P-45OhPCNI) is able to carry out the 6a-hydroxylation of lithocholic acid [56] . A comparison of this protein, the sequence of which is known [57] [58] [59] , with the lithocholic acid 6,/-hydroxylase will add another dimension to the correlation of structure with function, as these two enzymes catalyse reactions of identical regio-but opposite stereo-specificity on the same substrate. The two-way comparison of the lithocholic acid 6,/-hydroxylase with the rat androstenedione 6/?-hydroxylases on one hand, and with the human lithocholic acid 6a-hydroxylase on the other, should facilitate a more detailed understanding of 6fl-Hydroxylation of lithocholic acid those structural variables of the proteins that are critical to the recognition and orientation within the active site of their respective steroidal substrates.
